FDA approves 12-month flea treatment for dogs, marking veterinary breakthrough
By Docquan Louallen
FDA approves shot that protects dogs from fleas and ticks for 8-12 months
By Anthony Robledo
Blockbuster long acting flea and tick treatment for dogs coming after FDA approval
By Aislinn Murphy
Bravecto Quantum: A Paradigm Shift in Pet Care and Merck's Path to Dominance
QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health
See all articles & perspectives
F.D.A. Posts Collection of Letters Outlining Concerns About New Drugs
By Rebecca Robbins & Christina Jewett
Opinion | When accepting or rejecting new drugs, the FDA will be transparent
Opinion
By Marty Makary
FDA to Share Rejection Letters Drugmakers Often Keep Secret
By Damian Garde & Sam Hornblower
FDA releases ‘initial batch’ of more than 200 drug rejection letters
By Gabrielle Masson
US FDA publishes 200 complete response letters from archive in transparency drive
By Bhanvi Satija
See all articles & perspectives
FDA rejects Capricor’s cell therapy for Duchenne muscular dystrophy
By Adam Feuerstein
Capricor shares sink as US FDA declines to approve cell therapy
By Christy Santhosh
Capricor Plunges on FDA Rejection of DMD Cell Therapy
By Tristan Cesar Manalac
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
FDA rejects Capricor’s DMD cell therapy, asks for more data
See all articles & perspectives
Moderna gets full US approval for COVID shot in at-risk children 6 months and older
By Sriparna Roy & Bhanvi Satija
FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility
By Helen Branswell
Moderna COVID shot for kids cleared in face of RFK Jr. criticism
Moderna gets full FDA approval for kids COVID-19 vaccine
By Meg Hilling
MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients
See all articles & perspectives
The ‘Broken Things’ Makary Has Found at the FDA
By David Westin
FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion
Opinion
By Marty Makary
FDA Commissioner: ‘We want to focus on food’
By Diana Falzone
Hour 2 - Curing the Culture with MAHA | iHeartRadio | The Clay Travis and Buck Sexton Show
This Week at FDA: Makary celebrates first 100 days, Senate committee passes FDA budget bill, and more
By Ferdous Al-Faruque
See all articles & perspectives
US FDA declines to approve Ultragenyx's gene therapy for rare genetic disorder
By Shailesh Kuber & Shilpi Majumdar
See all articles & perspectives
Inside the Collapse of the F.D.A.
By Jeneen Interlandi
See all articles & perspectives
NIH grant cuts, FDA transparency questions, and biotech M&A
By Adam Feuerstein, Elaine Chen & Allison DeAngelis
FDA Offers to Trade Faster Drug Reviews for Lower US Prices
By Rachel Cohrs & Sam Hornblower
FDA's Makary calls for tying fast-review vouchers to lower US prices, without specifics
By Andrew Dunn
FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says
By Annika Kim Constantino
Understanding The Commissioner's National Priority Voucher
FDA Voucher Reforms: A Golden Opportunity in Biotech Valuations
See all articles & perspectives
US FDA approves gradual dosing for Lilly Alzheimer's drug
By Deena Beasley
FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease | Eli Lilly and Company
FDA Approves Updated Donanemab Labeling, BLA Accepted for Tividenofusp Alfa, Nipocalimab Outperforms FcRn Blockers
FDA Approves Modified Titration Dosing for Donanemab-azbt to Reduce ARIA-E Incidence in Early AD
What a New Dosing Plan Could Mean for People on Alzheimer’s Drug Kisunla
By Simon Spichak
See all articles & perspectives
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
See all articles & perspectives
America's Baby Formula Rules Are Due for an Update
By Kelli Pierce
FDA Calls for Streamlined Product Recall Communications to Protect Food for Infants and Children
FDA Infant Formula Safety Initiative Calls on Industry Leaders To Improve Public Recall Alerts
By Michael Adams
After kids get sick from Applesauce with lead and Infant Formula with Cronobacter, FDA leaders step up
By William Marler
FDA Shares Recall Communication Improvement Efforts, Encourages Transparency From Infant Formula and Baby Food Industry
See all articles & perspectives
Daily CBD Use at Consumer-Level Doses May Elevate Liver Enzymes, FDA-Led Trial Shows
See all articles & perspectives
FDA Grants Orphan Drug Designation to Quemliclustat in Pancreatic Cancer
By Tim Cortese
Arcus wins FDA orphan status for cancer drug (RCUS:NYSE)
By Nilanjana Basu
Arcus Biosciences' Investigational Pancreatic Cancer Treatment Gets US FDA Orphan Drug Status
Arcus Biosciences' Quemliclustat Gets Orphan Drug Status For Pancreatic Cancer
Arcus' Pancreatic Cancer Drug Gets FDA Orphan Status as Phase 3 Trial Nears Full Enrollment
See all articles & perspectives
E-cig businesses sue Wisconsin Department of Revenue over FDA authorization law
By Noah Cornelius
Wisconsin law cracking down on e-cigarettes just took effect. Now, distributors are suing.
By Madeline Heim
L:awsuit Challenges Wisconsin's PMTA Registry Law
By Jim Mcdonald
Vaping retailers mount challenge to 2023 Wisconsin law they say would end their business
By Chris Rickert
Wisconsin’s ban on many popular vapes met with pushback
By Sophia Lauber
See all articles & perspectives
Blueberries, mushrooms among FDA-led recalls over listeria concerns
By Brandy Beard
Blueberry Recall: FDA Issues Highest-Level Risk Warning for Listeria
By Andrea Rice
Understanding the Recent FDA Blueberry Recall
Organic Blueberry Recall Considered ‘Deadly,’ FDA Reports
By Emily Goldman
FDA Blueberry Recall Has Now Turned Deadly: Who Are The Most Vulnerable? Here's What You Need To Know
Opinion
See all articles & perspectives
FDA announces investigations into Salmonella, E. coli and Hepatitis A Outbreaks with no sources
By William Marler
FDA Clears AI-Based Visualization Software for Surgical Breast Cancer Care
By Russ Conroy
AI startup SimBioSys gets OK for breast cancer surgery platform
By Jon Asplund
SimBioSys Secures Third FDA Clearance for TumorSight™ Viz, Advancing AI-Powered Precision Surgery in Breast Cancer Care
U.S. FDA clears latest version of SimBioSys’s breast cancer platform
SimBioSys Earns 3rd FDA OK for TumorSight Viz AI Breast Cancer Tool
By Sam Brusco
See all articles & perspectives
FDA: Boar's Head Deli Brand Has Initiated Another Grocery Recall, This Time Affecting One State
By Kristine Gasbarre
Top F.D.A. Official Overrode Scientists on Covid Shots
By Christina Jewett
FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff
By Matthew Perrone
Trump-Kennedy attacks on vaccines and public health will kill millions globally
By Evan Blake
RFK Jr.'s FDA officials overrode career staff to limit COVID shots
By Alexander Tin
RAW: FILE: FDA OFFICIAL OVERRODE SCIENTISTS ON COVID VAX USE
See all articles & perspectives
DEA Crushes Illegal Marijuana - But Still Blocks MMJ's Legal Cannabis Drug for Huntington's
See all articles & perspectives
Food and Drug Administration staff cuts may hinder US biomedical innovation
By John T. Doolittle
FDA Issues Dire Warning For Two Recalled Chocolate Products
By Mike Moraitis
FDA Issues Highest Risk Warning for Nationwide Chocolate Recall
By Matthew Robinson
Weaver Nut Company Recalls Chocolate Nonpareils Due to Undeclared Milk Allergen
By Alexandria Portee
Weaver Nut Company chocolate recall under FDA's highest risk level
By Anthony Robledo
Popular chocolate treat recalled due to ‘presence of allergen’
By Amber Raiken
See all articles & perspectives
FDA stops Olympus devices from entering the US
By Paul Taylor
See all articles & perspectives
FDA approval of injectable lenacapavir marks progress for HIV prevention
The Drug That Could Revolutionize the Fight Against H.I.V.
By Jon Cohen
FDA approves powerful HIV prevention drug: What to know about Yeztugo
By Benjamin Ryan
'Miracle' HIV drug lenacapavir approved amid US budget cuts
Uptake of Gilead's Yeztugo will be swift, analyst says after discussion with HIV doc
By Kevin Dunleavy
See all articles & perspectives
Boston Scientific’s (BSX) FARAPULSE Approved by FDA for Expanded Labeling
See all articles & perspectives
Seven brands account for 1 in 7 US FDA refusals of Indian food, drug, cosmetic shipments
By Aggam Walia
Deadly Defect In Infant Breathing Systems Prompts Urgent Recall, FDA Says
By Chris Spiker
Recall: AirLife/Vyaire Removes Infant Heated Wire Circuits
Recalled infant breathing system used during ventilation could cause serious injury or death, FDA says
By Alexia Partouche
FDA issues Class I recall on infant heated wire circuits prone to disconnect
Infant breathing systems recalled over risk of deadly disconnection
See all articles & perspectives
New FDA priority review drug program comes with risks, questions
By Matthew Herper
Pune FDA Probes Food Safety Lapses After Cockroach, Glass Found in Meals
By Chaitraly Deshmukh
"Thought It Was Ice": Man Finds Glass In Bun Maska At Pune's Goodluck Cafe
'At first, I thought it was ice': Customer claims glass shard found in bun maska at iconic cafe in Pune;
By Anjali Jhangiani
VIDEO: Glass Shard Found In Bun Maska At Pune’s Iconic Goodluck Cafe
Glass Found in Bun Maska at Pune's Iconic Goodluck Café Sparks Food Safety Concerns
By Ankur Nikam
See all articles & perspectives
Massive Egg Recall Update: One Dead, 134 Infected
By Olivia Bria
See all articles & perspectives
FDA issues risk warning after mushrooms recalled nationwide
By Emma Kate Marsden
See all articles & perspectives